[R-(R*,R*)]-2-[2-[1-(p-Chlorphenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidiniumhydrogenfumarat
|
|
- CAS-Nr.
- 14976-57-9
- Bezeichnung:
- [R-(R*,R*)]-2-[2-[1-(p-Chlorphenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidiniumhydrogenfumarat
- Englisch Name:
- Clemastine fumarate
- Synonyma:
- hs592;tavist;Alagyl;agasten;lecasol;piloral;reconin;tavegil;tavegyl;trabest
- CBNumber:
- CB0376055
- Summenformel:
- C25H30ClNO5
- Molgewicht:
- 459.96
- MOL-Datei:
- 14976-57-9.mol
|
[R-(R*,R*)]-2-[2-[1-(p-Chlorphenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidiniumhydrogenfumarat Eigenschaften
- Schmelzpunkt:
- 158-162°C
- alpha
- D21 +16.9° (methanol)
- Siedepunkt:
- 154°C (rough estimate)
- Dichte
- 1.0247 (rough estimate)
- Brechungsindex
- 1.5790 (estimate)
- storage temp.
- 2-8°C
- L?slichkeit
- DMSO: soluble5mg/mL (clear solution; warmed)
- Aggregatzustand
- powder
- Farbe
- white to beige
- Optische Aktivit?t
- [α]/D +15 to +25°, c = 1 in methanol
- InChIKey
- PMGQWSIVQFOFOQ-YKVZVUFRSA-N
- CAS Datenbank
- 14976-57-9(CAS DataBase Reference)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
WGK Germany |
3 |
|
|
RTECS-Nr. |
UY0704600 |
|
|
HS Code |
2933992600 |
|
|
Giftige Stoffe Daten |
14976-57-9(Hazardous Substances Data) |
|
|
Toxizit?t |
LD50 in mice, rats (mg/kg): 730, 3550 orally; 43, 82 i.v. (Weimann) |
|
|
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
|
Sicherheit |
P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
[R-(R*,R*)]-2-[2-[1-(p-Chlorphenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidiniumhydrogenfumarat Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White Solid
Verwenden
Clemastine fumarate is a selective histamine H1 receptor antagonist (Ki = 0.26 nM) that also displays high affinity for muscarinic receptors (Ki = 16 nM). It has also recently been identified as a positive allosteric modulator of P2X7 receptor signaling. Clemastine fumarate has long been used to inhibit histamine-induced bronchoconstriction in asthma and airway hyperresponsive studies.
Definition
ChEBI: The fumaric acid salt of clemastine. An antihistamine with antimuscarinic and moderate sedative properties, it is used for the symptomatic relief of allergic conditions such as rhinitis, urticaria, conjunctivitis and in pruritic (severe itching) skin condi
ions.
Allgemeine Beschreibung
Dextrorotatory clemastine, R,R-2[2[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1- methylpyrrolidine hydrogen furnarate (1:1) (Tavist), has two chiral centers, each of which has the (R) absolute configuration. A comparison of the activities of the enantiomers indicates that the asymmetric center close to the terminal side chain nitrogen is of lesser importance to antihistaminic activity.
? This member of the ethanolamine series is characterized by a long duration of action, with an activity that reaches a maximum in 5 to 7 hours and persists for 10 to 12 hours. It is well absorbed when administered orally, and it is excreted primarily in the urine. The side effects are those usually encountered with this series of antihistamines. Clemastine is closely related to chlorphenoxamine, which is used for its central cholinergic-blocking activity. Therefore, it is not surprising that clemastine has significant antimuscarinic activity.
Biologische Aktivit?t
H 1 -receptor antagonist. Clinically-used antihistamine.
[R-(R*,R*)]-2-[2-[1-(p-Chlorphenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidiniumhydrogenfumarat Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
[R-(R*,R*)]-2-[2-[1-(p-Chlorphenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidiniumhydrogenfumarat Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 318)Lieferanten
14976-57-9([R-(R*,R*)]-2-[2-[1-(p-Chlorphenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidiniumhydrogenfumarat)Verwandte Suche:
- CLEMASTINE FUMARATE
- CLEMASTINE FUMARATE SALT
- (+)-2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrro
- (+)-2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrroli
- (+)-lfumarate(1:1)
- 1-methyl-2-(2-(methyl-p-chlorodiphenylmethyloxy)ethyl)pyrrolidine
- (2R)-2-[2-[(1R)-1-(4-CHLOROPHENYLETHOXY)]ETHYL]-1-METHYL-2-PYRROLIDINE FUMARATE
- 2-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine
- agasten
- aloginan
- alphamin
- anhistan
- clemanil
- clemastinehydrogenfumarate
- fuluminol
- hs592
- inbestan
- kinotomin
- lacretin
- lecasol
- lidinefumarate
- maikohis
- mallermin-f
- marsthine
- masletine
- meclastine
- meclastinehydrogenfumarate
- mecloprodine
- piloral
- pyrrolidine,2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methy
- reconin
- tavegil
- tavegyl
- tavist
- telgin-g
- trabest
- 1-Methyl-2-[2-(α-methyl-p-chlorobenzhydryloxy)ethyl]pyrrolidine fumarate salt
- Meclastine fumarate salt
- Clemastine hydrochloride
- [R-(R*,R*)]-2-[2-[1-(p-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidinium hydrogen fumarate
- (2R)-2-[2-[(1R)-1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine but-2-enedioic acid
- (+)-2-(2-((p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine
- Alagyl
- Tavegul
- CLEMASTINEFUMARATE,USP
- (+)-2-[2-[(p-Chloro-α-methyl-α-phenylbenzyl)oxy]ethyl]-1-methylpyrrolidine fumarate
- Meclastine fumarate
- Pyrrolidine, 2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, (2R)-, (2E)-2-butenedioate (1:1)
- Pyrrolidine, 2-[2-[(p-chloro-α-methyl-α-phenylbenzyl)oxy]ethyl]-1-methyl-, (+)-, fumarate (1:1) (8CI)
- Pyrrolidine, 2-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, [R-(R*,R*)]-, (E)-2-butenedioate (1:1)
- Xolamin
- Clemastine Fgumarate
- clemastine fumurate
- Clemastine Fumarate (250 mg)
- (2R)-2-[2-[(1R)-1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-Methylpyrrolidine (2E)-2-Butenedioate
- Clemastine for system suitability
- (+)-2-[2-[(p-Chloro-α-methyl-α-phenylbenzyl)oxy]ethyl]-1-methylpyrrolidine fumarate salt
- (2R)-2-[2-[(1R)-1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine fumarate salt